Microvascular disease and heart failure with reduced and preserved ejection fraction in type 2 diabetes
Abstract Aims Identification of patients with type 2 diabetes (T2D) at increased risk of incident heart failure (HF) beyond traditional risk factors such as prior myocardial infarction (MI) might allow selection of patients who would benefit from preventative treatment. Microvascular disease (MiVD)...
Saved in:
Main Authors: | Ify R. Mordi, Aaron Tee, Colin N. Palmer, Rory J. McCrimmon, Alexander S.F. Doney, Chim C. Lang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-06-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.12669 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SS-OCTA assessment of fundus microvascular changes and their correlation with coronary lesion severity in severe coronary heart disease
by: Dandan Zong, et al.
Published: (2024-12-01) -
Economic impact of heart failure with preserved ejection fraction: insights from the ALDO‐DHF trial
by: Djawid Hashemi, et al.
Published: (2020-06-01) -
Challenges in the diagnosis of heart failure with preserved ejection fraction in individuals with obesity
by: Bas M. van Dalen, et al.
Published: (2025-02-01) -
Coronary Microvascular Dysfunction: Insights on Prognosis and Future Perspectives
by: Filippo Luca Gurgoglione, et al.
Published: (2025-01-01) -
Liver fibrosis stage classification in stacked microvascular images based on deep learning
by: Daisuke Miura, et al.
Published: (2025-01-01)